Vixiar Medical
Robert Storey serves as Managing Partner at The LaunchPort, a medical device manufacturing accelerator, and is also Principal at The MVR Company, focusing on innovation for emerging growth companies. Storey holds the position of Vice Chairman on the Maryland Life Sciences Advisory Board and is actively involved with Johns Hopkins University in various roles, including Director of the Evaluation Core for NeuroTech Harbor and Executive in Residence at Johns Hopkins Tech Ventures. Additional roles include Portfolio Executive for the NIH's RADx program, National Faculty for I-Corps at both the NIH and NSF, and advisory positions with Wexford Science & Technology and Annoviant. Storey has extensive experience in medical device commercialization and innovation, underpinned by a BSChemEng in Chemical Engineering and a BS in Chemistry from the University of Arkansas.
This person is not in any teams
This person is not in any offices
Vixiar Medical
Vixiar Medical, Inc. is a Maryland company founded to commercialize unique technologies for the non-invasive monitoring of cardiopulmonary diseases, particularly those with a significant clinical and economic burden. The Company’s first product, Indicor ™, has been licensed from Johns Hopkins University and is a portable, hand-held device for assessing cardiac filling pressures for monitoring congestive heart failure (HF) at the point of care in hospitals, physician’s offices, nursing facilities and other clinical settings. The device is an alternative to more labor intensive, more expensive, invasive or less accurate approaches and is designed to prevent hospital readmissions and improve clinical management of HF.